Cryo-Cell International
CCEL
10 hedge funds and large institutions have $7.88M invested in Cryo-Cell International in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
7.7% more ownership
Funds ownership: 0% → 7.7% (+7.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
+$6.12M |
| 2 |
MPWT
MassMutual Private Wealth & Trust
Windsor,
Connecticut
|
+$937K |
| 3 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$536K |
| 4 |
MCM
Maryland Capital Management
Towson,
Maryland
|
+$241K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$157K |
Top Sellers
CCEL Hedge Fund Activity: Q3 2021 in Review
10 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q3 2021, worth a combined $7.88M.
Buyers outnumbered sellers: 10 funds opened new CCEL positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ISZO Capital Management, opening a new position worth an estimated $6.12M.
- 10 institutional investors held Cryo-Cell International (CCEL) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $7.88M of Cryo-Cell International stock for Q3 2021.
- 10 funds opened new Cryo-Cell International positions in Q3 2021 and 0 closed out, a net change of +10 holders.
- The largest Cryo-Cell International buyer in Q3 2021 was ISZO Capital Management, an estimated $6.12M added.
Based on aggregated 13F filings for Q3 2021.